Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The L-CMD Research Foundation is a non-profit organization dedicated to accelerating the development of treatments and a cure for Laminin-alpha2-Related Congenital Muscular Dystrophy (LAMA2-CMD). The foundation focuses on funding high-impact research, fostering collaboration between scientists and clinicians, and supporting the patient community. Their portfolio includes projects exploring gene therapy, protein replacement, and small molecule interventions to address the underlying genetic cause of the disease. By bridging the gap between basic science and clinical application, the foundation aims to bring life-changing therapies to patients worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on L-CMD Research Foundation.